Role of HAO2 in rats with chronic kidney disease by regulating fatty acid metabolic processes in renal tissue
Abstract
Fibrosis is a progressive, often irreversible histologic manifestation of chronic and end-stage renal disease. In this study, single-cell transcriptome sequencing technology was used to sequence and analyze blood and kidney tissue cells in normal control rats and rats with chronic kidney disease (CKD), focusing on key cell populations and functional enrichment to explore the pathogenesis of CKD. Oil red O staining and ELISA were used to detect lipid droplets and free fat acid (FFA). RT-PCR, WB were used to verify the differential gene HAO2 and fatty acid metabolic process in tissue to ensure the reliability of single-cell sequencing results. We successfully established a single-cell transcriptome atlas of blood and kidney tissue in rats with CKD, which were annotated into 14 cell subsets (MPCs, PT, Tc, DCT, B-IC, A-IC, CNT, ALOH, BC, Neu, Endo, Pla, NKT, Baso) according to marker gene, and the integrated single-cell atlas of rats showed a significant increase and decrease of MPCs and PTs in the model group, respectively. Functional analysis found extensive enrichment of metabolic-related pathways in PT cells, includes fatty acid metabolic process, cellular amino acid metabolic process and generation of precursor metabolites and energy. Immunohistochemical experiments determined that the differential gene HAO2 was localized in the renal tubules, and its expression was significantly reduced in model group compared with control, and oil red O staining showed that lipid droplets increased in the model group. ELISA assay showed that ATP content decreased in the model group and FFA increased in the model group. ACOX1, PPAR, PGC1 were decreased in the model group, while genes and proteins were increased after overexpression of HAO2, and the AMPK and ACC phosphorylated proteins were increased. Therefore, HAO2 may be an important regulator of fatty acid metabolic processes in CKD, and overexpression of HAO2 can enhance fatty acid metabolism by promoting fatty acid oxidation pathway.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis
V. Miguel, J. Tituana, … S. Lamas·bioRxiv·Feb 18, 2020
- JAK-STAT pathway activation compromises nephrocyte function in a Drosophila high-fat diet model of chronic kidney disease
Yunpo Zhao, Jianli Duan, … Zhe Han·bioRxiv·Mar 7, 2024
- HuR inhibition attenuates hypertension and fibrosis in chronic kidney disease
Lili Zhuang, Zhou Wang, … Yufeng Huang·bioRxiv·Feb 25, 2026
- NAD+ activates renal metabolism and protects from chronic kidney disease in a model of Alport syndrome
Bryce A. Jones, Debora L. Gisch, … Moshe Levi·JCI InsightPeer-reviewed·Mar 9, 2025
- Vascular transcriptional and metabolic changes precede progressive intra-renal microvascular rarefaction in autosomal dominant polycystic kidney disease
Gizem Yilmaz, Santu Kumar Singha, … Maria Valentina Irazabal·American Journal of Physiology-Renal PhysiologyPeer-reviewed·Feb 5, 2026
- Aortic Valve Remodeling in Chronic Kidney Disease: A Mineralocorticoid Receptor-Driven Mechanism Involving NGAL and TLR4 Pathways
Tania Sánchez‐Bayuela, Matthieu Soulié, … Frédéric Jaisser·bioRxiv·Sep 12, 2025